You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

The Non-Hodgkin Lymphoma Case Clinic

  • Authors: Julie M. Vose, MD, MBA; Gilles Salles, MD, PhD; Kami Maddocks, MD
  • CME / ABIM MOC / CE Released: 10/20/2022
  • Valid for credit through: 10/20/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, nurses, nurse practitioners, advanced practice nurses, and pharmacists.

The goal of this activity is for learners to be better able to incorporate key developments in lymphoma to patient care plans.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data that should inform decision-making in non-Hodgkin lymphoma (NHL)
  • Have greater competence related to
    • Applying clinical trial data in treatment plans for NHL
    • Managing adverse effects of NHL therapies
  • Demonstrate greater confidence in their ability to
    • Personalize treatment for patients with NHL


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Julie M. Vose, MD, MBA

    Professor, Internal Medicine
    Division of Oncology & Hematology
    University of Nebraska Medical Center
    Omaha, Nebraska

    Disclosures

    Julie M. Vose, MD, MBA, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; AstraZeneca; Bristol Myers Squibb; Daichi Sankyo; Genentech; Janssen; Johnson & Johnson; Lilly; MEI Pharma; Pharmacyclics
    Research funding from: AbbVie; AstraZeneca; Bristol Myers Squibb; Daichi Sankyo; Genentech; Janssen; Johnson & Johnson; Lilly; MEI Pharma; Pharmacyclics

  • Gilles Salles, MD, PhD

    Professor of Medicine
    Chief of the Lymphoma Service
    Memorial Sloan Kettering Cancer Center
    New York, New York

    Disclosures

    Gilles Salles, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Beigene; Bristol Myers Squibb/Celgene; Debiopharm/Velosbi/Ipsen; Epizyme; Genentech/Roche; Genmab; Incyte; Janssen; Kite/Gilead; Loxo; Milteniy; Molecular Partners; Morphosys; Nordic Nanovector; Novartis; Rapt; Takeda

  • Kami Maddocks, MD

    Professor of Clinical Internal Medicine
    Division of Hematology
    The Ohio State University
    Columbus, Ohio

    Disclosures

    Kami Maddocks, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Acerta Pharma; ADC Therapeutics; AstraZeneca; BeiGene; Bristol Myers Squibb; Genentech; Genmab; Gilead Sciences; Incyte; Janssen; Kite Pharma; Lilly; MorphoSys; Pharmacyclics
    Research funding from: Bristol Myers Squibb; Pfizer; Pharmacyclics

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Lisa Cockrell, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number JA0007105-0000-22-369-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

The Non-Hodgkin Lymphoma Case Clinic

Authors: Julie M. Vose, MD, MBA; Gilles Salles, MD, PhD; Kami Maddocks, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 10/20/2022

Valid for credit through: 10/20/2023

processing....

Educational Impact Challenge

The goal of this activity is for learners to be better able to incorporate key developments in lymphoma to patient care plans.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print